 |
| | | | | | |
|---|
 | 2014 |
| |
 | 2015 |
| |
| 01 |
| |
| 02 |
| |
| 03 |
| |
| 04 |
| |
| 05 |
| |
| 06 |
| |
| 07 |
| |
| 08 |
| |
| 09 |
| |
| | 09/29/2015 | 08:00 AM | | Displaying Futures: Merck KGaA, Darmstadt, Germany, Shapes New Focus at Adaptive Architectures and Smart Materials Conference |   | |
| | 09/28/2015 | 07:45 AM | | EMD Millipore Publishes White Paper Highlighting Importance of Emerging Biotech Companies for Discovery of New Drugs During Recent Emerging Biotech Executive Summit | | |
| | 09/28/2015 | 08:00 AM | | Merck KGaA, Darmstadt, Germany, Progresses Toward Completion of Sigma-Aldrich Acquisition | | |
| | 09/25/2015 | 01:00 PM | | Merck KGaA, Darmstadt, Germany, and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma | | |
| | 09/24/2015 | 11:00 PM | | Merck KGaA, Darmstadt, Germany, and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab | | |
| | 09/21/2015 | 10:00 AM | | New Depth with Xirallic® NXT Tigris Blue from Merck KGaA, Darmstadt, Germany | | |
| | 09/18/2015 | 09:00 AM | | Merck KGaA, Darmstadt, Germany, and Tridonic Enter Into License Agreement for White LEDs | | |
| | 09/15/2015 | 03:00 PM | | Merck KGaA, Darmstadt, Germany, Streamlines Healthcare Management as Business Enters New Strategic Phase | | |
| | 09/14/2015 | 03:00 PM | | EMD Millipore Introduces Enhancements to its EMPROVE® Program of Pharmaceutical Raw Materials to Facilitate Risk Assessment | | |
| | 09/11/2015 | 10:00 AM | | Merck KGaA, Darmstadt, Germany, and Pfizer to Present Updates for Avelumab at the European Cancer Congress 2015 | | |
| | 09/11/2015 | 08:00 AM | | Merck KGaA, Darmstadt, Germany, Intends to Submit Cladribine Tablets to Treat Multiple Sclerosis for Registration in Europe | | |
| 10 |
| |
| 11 |
| |
| 12 |
| |
| 2016 |
| |
| 2017 |
| |
| 2018 |
| |
|